Tesla Loses Ground in Europe as BYD Accelerates EV Market Share in 2025 
ASML’s EUV Monopoly Powers the Global AI Chip Boom 
Micron to Expand Memory Chip Manufacturing Capacity in Singapore Amid Global Shortage 
Citigroup Faces Lawsuit Over Alleged Sexual Harassment by Top Wealth Executive 
Shell Plc Downgraded by RBC as Market Headwinds Pressure Valuation 
Noble Corporation Secures $1.3 Billion in New Contracts, Strengthening Offshore Drilling Backlog 
LVMH Investors Watch Earnings Closely as Luxury Recovery Faces New Challenges 
NTSB Opens Investigation Into Waymo Robotaxis After School Bus Safety Violations in Texas 
Delta Air Lines Operates Reduced Flight Schedule as Winter Storm Disrupts U.S. Travel 
Hyundai Motor Shares Slide After Trump Signals Higher U.S. Tariffs on South Korean Goods 
BYD and Exxon Mobil Strengthen Hybrid Technology Partnership 
Embraer Targets Growth as Regional Jet Demand Surges Post-Pandemic 
Samsung Set to Begin HBM4 Production for Nvidia and AMD 
Trump Administration Takes Stake in USA Rare Earth to Boost U.S. Critical Minerals Supply 
California Governor Gavin Newsom Launches Review Into Alleged TikTok Content Suppression After U.S. Ownership Deal 
BETHLEHEM, Pa., May 16, 2017 -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced that Douglas A. Michels, President and CEO, will speak to the investment community at the UBS Global Healthcare Conference in New York, New York. The conference will be simultaneously webcast over the Internet.
Mr. Michels is scheduled to speak on May 23, 2017, at approximately 8:30 AM Eastern Time (5:30 AM Pacific Time). Interested investors can access the live webcast of the presentation by going to OraSure Technologies’ web site, www.orasure.com, and clicking on the Investor Info link. A replay of the webcast will be available on OraSure Technologies’ web site for seven days. Alternatively, you can access the live webcast of the presentation via the following link: https://cc.talkpoint.com/ubsx001/052217a_as/?entity=37_J1YMCU8.
About OraSure Technologies
OraSure Technologies is a leader in the development, manufacture and distribution of point of care diagnostic and collection devices and other technologies designed to detect or diagnose critical medical conditions. Its first-to-market, innovative products include rapid tests for the detection of antibodies to HIV and HCV on the OraQuick® platform, oral fluid sample collection, stabilization and preparation products for molecular diagnostic applications, and oral fluid laboratory tests for detecting various drugs of abuse. OraSure's portfolio of products is sold globally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, research and academic institutions, distributors, government agencies, physicians' offices, commercial and industrial entities and consumers. The Company's products enable healthcare providers to deliver critical information to patients, empowering them to make decisions to improve and protect their health. For more information on OraSure Technologies, please visit www.orasure.com.
Company contact: Ronald H. Spair Chief Financial Officer 610-882-1820 [email protected] www.orasure.com Shauna White Corporate Marketing Manager 484-353-1575 [email protected] www.orasure.com
